BV-R2 combination shows survival benefit across high-risk subgroups.
Ami Ali, PharmD, BCOP
Advertisement
Articles by Ami Ali, PharmD, BCOP
The FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma.
The approval marks a significant milestone in the treatment of a rare and aggressive subtype of acute leukemia.
Pharmacists will play a significant role in TKI adherence rates among patients.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
ACIP Meeting: COVID-19 Vaccines to be Administered Through Shared Clinical Decision-Making
2
ACIP Meeting: Combined MMRV Vaccine, Hepatitis B Vaccine Restricted for Some Age Groups
3
Intelligent Pharmacy: Leveraging AI and Automation to Enhance Patient Care and Pharmacist Roles
4
FDA Approves Keytruda Qlex Subcutaneous Injection for Adult and Pediatric Patients With Solid Tumors
5
